The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

著者: Biswajit Chowdhury, Albert Z. Luu, Vincent Z. Luu, M. Golam Kabir, Yi Pan, Hwee Teoh, Adrian Quan, Sandra Sabongui, Mohammed Al‐Omran, Deepak L. Bhatt, C. David Mazer, Kim A. Connelly, Subodh Verma, David A. Hess - Biochemical and Biophysical Research Communications 2020 被引用: 140